Competitive landscape · Partner briefing · August 2026

Everyone monitors a thesis.
Nobody keeps the record.

Seven products already sell thesis tracking, evidence citations and decision journals. None of them connects the whole chain — from the filing that changed your mind to the outcome that proved you right or wrong. That chain is ClassicInvestor.

ProductClassicInvestor Competitors assessed7 direct · 5 adjacent Capabilities compared16 across 8 journey stages Evidence basePublic product material, Aug 2026

01 — The conclusion firstThe market is not empty, and that is the most useful thing we know

Competitors already ship almost every feature that could superficially define this product. Any pitch built on a single capability is already answered by someone with a live product and paying users.

None of these is defensible on its own

“AI monitors your thesis.” · “Chat with company filings.” · “Keep an investment journal.” · “Version-control your thesis.” · “Connect your brokerage account.” · “Get alerts when the thesis changes.”

Helm Terminal already combines linked portfolios, thesis pillars, automatic event monitoring, exact source evidence, prioritised actions and tax-aware context. subThesis already combines version-controlled theses, assumptions, source-linked claims, decision records, scenario branches and outcome review. Journalytic already captures decisions, predictions, probabilities, feelings, checklists, opportunity cost and behavioural feedback.

7
Direct and near-direct competitors assessed
0 / 7
Cover all eight journey stages
6 / 8
Best coverage — subThesis
0 / 7
Rated Full on general financial analysis

Where the opening actually is

The gap is not a missing screen. It is the absence of a dependable link between what an investor knew, what they believed, what they did, and what happened. Each competitor owns a segment of that chain and stops.

The full chain — and where the market stops

Authoritative evidence→ Exact claim→ Investor assumption→ Risk / invalidator→ Decision→ Capital allocated→ Monitoring event→ Actual outcome→ Process review→ Investor calibration→ Cross-company learning

Gold = no reviewed product was publicly evidenced as reaching these links from authoritative company evidence.

Other products help an investor research a company, monitor a thesis, or review a decision. ClassicInvestor shows how evidence changed reasoning, how reasoning changed capital, and how the outcome changed the investor. The differentiation statement, in one sentence
ClassicInvestor · Competitive landscape01

02 — PositioningClassicInvestor

The name is the position. The classic discipline of fundamental investing — read the filing, write down what must stay true, size the position, review honestly — is not new. What has never existed is a system that keeps that discipline intact across years and proves whether it worked.

What we are

A permanent, evidence-anchored record of how an investor decides. Every conclusion keeps the filing it came from, the assumption it rested on, the risk that could break it, the position it justified, the events that followed and the outcome that resolved it.

What we are not

Not another portfolio news brief. Not another Git-backed thesis notebook. Not another chat-with-filings box. Not another dashboard of financial tables — those are table stakes and already well supplied.

The primary object

A point-in-time investment case: the evidence available then, the claims drawn from it, the investor's assumptions and confidence, the risks and invalidators, the valuation and expected return, the decision and the alternatives rejected, the capital committed, and the resolution rule that will later settle it.

Why it compounds

Every resolved case improves the next one. Calibration, failure patterns and management track records accumulate into something a competitor cannot copy by shipping a feature — because it is the customer's own history.

The three things we must match before we can differentiate

Exact citations · thesis pillars and assumption tracking · portfolio context and alerts. These are now expected. They buy us the right to compete; they do not win.

ClassicInvestor · Positioning02

03 — The competitorsThe portfolio-aware incumbent

Helm Terminal 4 / 8 stages helmterminal.dev

Who it is for. Self-directed investors with holdings spread across accounts who want a daily, portfolio-aware answer to “what changed and what needs action?”

What it does well. Low-friction brokerage connection, whole-portfolio visibility, ETF look-through, exact sourced evidence, daily prioritisation, action-oriented monitoring, and tax intelligence that runs all year.

Where it stops. It answers “what changed in what I own?” far better than “what did I believe, why did I act, and what did I learn?” No publicly evidenced thesis version history, original decision record, process-versus-outcome review, or investor calibration.

Helm Terminal portfolio dashboard
Helm — portfolio view with diversification score, look-through single-name risk and a live market-intelligence rail linked to holdings.
Helm daily brief
The Daily Brief — an agent-written morning brief on the user's own portfolio.
Helm actions inbox
Actions — every decision ranked by what it is worth in dollars.

What ClassicInvestor does differently

Match the portfolio-aware monitoring and the exact citations — then connect every alert to a versioned assumption, the prior decision, the position size, the expected outcome and the later review. Helm tells you what moved. We keep why you were there in the first place.

ClassicInvestor · Competitors03

04 — The competitorsThe closest thing to a direct competitor

subThesis 6 / 8 stages — closest subthesis.app

Who it is for. Thesis-driven fundamental investors and independent researchers who want one persistent research record instead of fragmented notes and spreadsheets.

What it does well. Research continuity, version control, evidence-linked claims, scenario branches, structured risks, decisions and outcomes — with an open, exportable, Markdown/Git-backed history.

Where it stops. It preserves a company thesis well, but does not publicly demonstrate portfolio-wide risk governance, capital-weighted calibration, opportunity cost, behavioural analytics, executive commitment tracking, or cross-company learning.

subThesis institutional holdings view
subThesis — institutional fund holdings with quarter-over-quarter position changes, exits and 13D/13G context.
subThesis workspace
The research workspace — versioned thesis, claims and evidence in one record.
subThesis product page
“Preserve what you believed, connect it to the evidence, and see what changed.”

What ClassicInvestor does differently

Adopt the open, portable, versioned research model — then extend it into portfolio allocation, resolved outcomes, personal calibration and cross-company evidence relationships. subThesis is the benchmark to beat, and the closest thing to a direct competitor in this set.

ClassicInvestor · Competitors04

05 — The competitorsThe process specialist

Journalytic 3 / 8 stages journalytic.com

Who it is for. Investors who want to improve their decision process, recognise behavioural patterns, and separate repeatable skill from luck.

What it does well. Decision journaling, probabilistic predictions, emotions, checklists, consequences, opportunity cost and behavioural feedback — the richest process capture in the set.

Where it stops. No primary-source company ingestion, no exact filing evidence, no integrated financial analysis, no automatic thesis monitoring. It can explain the investor's process but cannot independently reconstruct the company evidence that should have informed it.

Journalytic insights dashboard
Journalytic — process analytics: entry heat map, decision counts, tags, ideas and behavioural metrics over time.
Journalytic journal view
The journal — entries, decisions and predictions in one searchable record.
Journalytic product positioning
Positioned around augmented decision-making rather than company research.

What ClassicInvestor does differently

Build Journalytic-quality process capture directly into the evidence and portfolio workflow. Journaling must never be a separate destination the user has to remember to maintain — that is precisely why most investment journals die.

ClassicInvestor · Competitors05

06 — The competitorsThe lighter field

Four further products compete directly for the same user. Each is operationally simpler, and each stops earlier.

MyThesis2 / 8

Does well: simple setup, clear thesis pillars, continuous event scanning, understandable Supported / Challenged verdicts.

Stops at: the verdict. Thin decision history, limited calibration, limited source-text depth.

We differ: use verdicts only as summaries. Keep the exact evidence, the changed assumption, alternative readings and the resolution criteria underneath.

SYNESI3 / 8

Does well: conviction journal, structured assumptions, exit criteria, AI challenge, bias scanning, thesis-health dashboard, audit trail.

Stops at: source-level provenance. Its bias framing narrows part of our proposed whitespace, so this one is worth watching closely.

We differ: anchor the same discipline to authoritative evidence rather than to self-report alone.

Horyzon2 / 8

Does well: mobile-first, low friction, thesis attached to each holding, goals and timelines, no broker login required.

Stops at: lightweight tracking. No research depth.

We differ: a different user entirely — we should not chase this simplicity at the cost of the record.

ThesesWatch3 / 8

Does well: measurable assumptions, numeric thresholds, explicit invalidation rules, background monitoring, risk limits.

Stops at: the threshold alert.

We differ: keep the numeric rigour, then carry the breach into a decision and a resolved outcome.

A note on the screenshots. This briefing shows real product screenshots for Helm Terminal, subThesis and Journalytic, captured from their live products in August 2026. We do not hold captures for MyThesis, SYNESI, Horyzon or ThesesWatch, so none are shown rather than substituted — the assessments above are drawn from their current public product descriptions.

Adjacent benchmarks — not competitors, but they set the bar

PlatformWhat it makes table stakesWhere it stops
FintoolFast AI search across filings and transcripts with cited answers and company timelinesRetrieval and synthesis. Acquired by Microsoft in April 2026 — raising distribution risk for generic “chat with filings”
AlphaSense · BamSEC · TegusEnterprise document search, filing redlines, broker research, expert transcriptsInstitutional research workflow
TIKRGlobal coverage, estimates, screening, valuation, ownership, transcriptsResearch and monitoring, not personal calibration
KoyfinTerminal-style dashboards across fundamentals and macro Data exploration, not thesis evolution
Simply Wall StAccessible visual fundamentals at global scale Standardised visuals, not exact evidence or decision records

The lesson: we should not compete on the number of financial tables, the speed of generic document chat, or the polish of an ordinary company dashboard. Those are necessary and already well supplied.

ClassicInvestor · Competitors06

07 — Capability comparisonSixteen capabilities, seven products

Full central and operational · Part narrow, manual or secondary · No evidenced absent · Unk insufficient evidence — Unknown must never be read as No.

Research, data, portfolio and monitoring

ProductResearch /
evidence		Financial
analysis		 Portfolio
tracking		Brokerage
sync		Event
monitoring		 AI
analysis		Source
citations		Alerts
HelmFullPartFullFullFullFullFullFull
subThesisFullPartPartPartFullFullFullPart
JournalyticNoNoPartNoNoUnkNoFull
MyThesisPartPartPartNoFullFullPartFull
SYNESIPartPartPartUnkPartFullUnkFull
HoryzonPartPartFullNoPartFullUnkUnk
ThesesWatchPartPartPartUnkPartUnkUnkFull

Thesis, decision, risk, outcome and learning

ProductThesis
creation		Thesis
monitoring		 Assumption
tracking		Decision
journal		Risk
monitoring		 Outcome
tracking		Post-invest
review		Bias
feedback
HelmPartFullPartUnkPartPartUnkUnk
subThesisFullFullFullFullFullFullFullUnk
JournalyticPartNoPartFullPartFullFullFull
MyThesisFullFullPartUnkPartUnkUnkUnk
SYNESIFullFullFullPartPartPartFullFull
HoryzonFullPartPartPartPartPartPartUnk
ThesesWatchFullFullFullUnkFullFullPartUnk

Read the columns, not the rows

Thesis creation is Full for six of seven — it is fully commoditised. Monitoring is Full for five — “monitor my thesis” is a crowded promise. But financial analysis is Full for none, decision capture is uneven, and bias feedback is Full for only two. The right-hand side of this table is where the market thins out.

ClassicInvestor · Capability matrix07

08 — Journey coverageEight stages. Nobody covers all of them.

ProductEvidenceAnalysisThesis DecisionPortfolioMonitoringOutcomeReview Full
HelmFullPartFullUnkFullFullPartUnk4
subThesisFullPartFullFullPartFullFullFull6
JournalyticNoNoPartFullPartNoFullFull3
MyThesisPartPartFullUnkPartFullUnkUnk2
SYNESIPartPartFullPartPartFullPartFull3
HoryzonPartPartFullPartFullPartPartPart2
ThesesWatchPartPartFullUnkPartFullFullPart3

Where each workflow actually stops

ProductIts workflow, end to end
Helmposition and portfolio state → thesis pillars → monitored evidence → prioritised action. Stops after the action.
subThesisevidence and research → versioned thesis → assumptions and risks → decisions → monitoring → outcome review. Stops before portfolio-wide calibration.
Journalyticinvestor thought and emotion → decision or prediction → consequence → behavioural review. Never starts from company evidence.
MyThesis · ThesesWatchthesis assumptions → automated monitoring → verdict or threshold alert. Stops at the verdict.
SYNESIthesis and assumptions → AI challenge → monitoring → review. Stops before source-level provenance.
Horyzonportfolio → thesis note → company update → mobile insight. Stops at lightweight tracking.
Exact evidence is becoming table stakes. Thesis creation is heavily commoditised. Monitoring is a crowded promise. Learning exists — but it rarely begins with authoritative company evidence, and that is the seam. Stage-level reading of the market
ClassicInvestor · Journey coverage08

09 — Where we winCopy, improve, reject

Match — table stakes

  • Exact citations to primary sources
  • Thesis pillars and assumption tracking
  • Version history and diffs
  • Portfolio context and exposure
  • Event-aware alerts
  • AI challenge to the thesis
  • Decision records and outcome capture
  • Exportable, portable history

Reject — do not copy

  • Another portfolio news brief
  • Another Git-backed thesis notebook
  • Another chat-with-filings box
  • Verdict-first “Supported / Challenged” labels as the product
  • Engagement-ranked feeds
  • Competing on the number of financial tables

Win — the durable layer

  • Canonical evidence and provenance. Source document, exact span, source version, publication time, content hash, parser version, rights class.
  • Point-in-time investment case. Everything that was true when the decision was made, frozen and retrievable.
  • Dynamic risk register. Each risk with evidence, probability, impact, invalidation rule, monitoring rule and current state.
  • Outcome resolver. Explicit resolution triggers so decisions cannot stay open forever — the single thing that makes learning possible.
  • Investor calibration. Systematically overconfident, late, early or biased — measured against the investor's own recorded expectations.
  • Executive commitment ledger. Management promises as exact, dated commitments with deadlines, revisions and later outcome labels.
  • Cross-company learning. Similar assumptions, promises, risks and failure patterns found elsewhere in the investor's own history.

Priority sequence

PCapabilityThe user problem it solves
P0Canonical evidence & provenance layerInvestors cannot verify AI claims or reconstruct what was known at decision time
P0Integrated First Pass workspaceToo much time collecting data before deciding whether a company deserves deep work
P0Versioned thesis, claim and assumption modelStatic notes hide how thinking changed
P0Dynamic risk registerImportant risks disappear into narrative and are never monitored
P0Decision and expected-outcome recordInvestors forget why they acted, then rewrite history
P0Event-to-assumption monitoringOrdinary alerts create noise and never explain relevance
P1Portfolio and allocation contextSecurities are analysed individually but capital is allocated at portfolio level
P1Monitoring inbox ranked by decision relevanceUsers cannot tell important changes from routine information
P1Outcome resolver and review workflowDecisions stay open indefinitely, preventing learning

What we should be able to say in twelve months that nobody else can

“Here is the filing sentence that changed your mind in March, the assumption it rewrote, the position you sized because of it, the event that tested it in August, and whether you were right — measured against what you said would happen.”

ClassicInvestor · Where we win09

10 — In closingThe moat is the customer's own history

Every feature in this briefing can be copied. A competitor can ship citations in a quarter and thesis versioning in two. What cannot be copied is five years of one investor's evidence, decisions, outcomes and calibration, connected end to end — because it is not a feature, it is an accumulation.

ClassicInvestor — the complete record

Evidence→ Claim→ Assumption→ Risk→ Decision→ Capital→ Event→ Outcome→ Review→ Calibration→ Cross-company learning

What this briefing establishes

  • The market is real, funded and shipping — not empty.
  • Seven direct competitors; none covers the full journey.
  • subThesis at 6 of 8 stages is the benchmark to beat.
  • Table stakes are well defined and must be matched, not argued with.
  • The whitespace is the second half of the chain — review, calibration and cross-company learning, anchored to authoritative evidence.

What remains to be proven

  • Private paid workflows, brokerage behaviour, export quality, data history and alert accuracy still require hands-on product testing.
  • Four of seven competitors are assessed from public materials only, with no captures.
  • “Unknown” in these matrices means insufficient evidence — never absence.
Other products help an investor research a company, monitor a thesis, or review a decision.
ClassicInvestor shows how evidence changed reasoning, how reasoning changed capital, and how the outcome changed the investor. ClassicInvestor · positioning statement

Sources. Public product material as of August 2026 — helmterminal.dev · subthesis.app · journalytic.com · mythesis.ai · synesi.app · horyzonapp.com · theseswatch.com · fintool.com · tikr.com. Screenshots captured from live products. Assessments use a conservative public-evidence rubric; they are analytical outputs, not vendor-reported statistics.

Prepared for partner distribution. Confidential.

ClassicInvestor · Competitive landscape · August 202610